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May 26, 2009:2010–3itamin D Deficiency
nd Myocardial Dysfunction
n a recent review, Lee et al. (1) have outlined the role of vitamin
deficiency as a cardiovascular risk factor. In this letter, we want
o point out that direct effects of vitamin D on the myocardium
ight partially explain the link between vitamin D deficiency
nd adverse cardiovascular outcome. This notion is supported
y observations that human cardiomyocytes express enzymes for the
etabolism of vitamin D as well as a functional vitamin D receptor,
hich is up-regulated in myocardial hypertrophy (2,3). In animal
odels of heart failure, active vitamin D treatment was shown to
educe cardiac hypertrophy and to attenuate myocardial dysfunction
4). Several genes that are up-regulated in the course of cardiac
ypertrophy, involving those of natriuretic peptides and renin, are
own-regulated by vitamin D (4). Importantly, there exists increasing
olecular and clinical evidence that a sufficient vitamin D status is
equired for maintenance of diastolic function of the heart (3,4).
urthermore, there are several case reports of vitamin D–deficient
hildren with dilated cardiomyopathy that could be successfully
reated with vitamin D and calcium (5). In line with this are data from
cohort of over 3,000 patients referred for coronary angiography that
howed a significant association of vitamin D deficiency with reduced
eft ventricular function (6). In the same study cohort, vitamin D
eficiency was prospectively associated with deaths caused by heart
ailure and with sudden cardiac deaths (6). These results fit well with
bservations that active vitamin D treatment in hemodialysis patients
as shown to regress cardiac hypertrophy and to reduce QT interval
nd dispersion (4,7). In conclusion, there exists compelling evidence
hat vitamin D supplementation might be useful for the prevention
nd treatment of myocardial diseases.
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itamin D, Outdoor Happiness,
nd the Meaning of Deficiency
ee et al. (1) informatively review the emerging evidence for
itamin D as a lifestyle risk factor for cardiovascular disease. Two
verlooked points should be highlighted. First, as the investigators
ote, the great majority of vitamin D is derived from sun exposure,
ather than dietary consumption. Thus, effect estimates in studies
f vitamin D levels and cardiovascular risk may be confounded, at
east in part, by challenging-to-measure differences in lifestyles,
ehaviors, dispositions, and opportunities that lead individuals to
njoy and spend time in the sun, such as physical and social
ctivities. Whereas vitamin D itself may still provide benefit, being
utside and enjoying these activities are likely to provide additional
ealth benefits that erroneously may be attributed as effects of
itamin D.
Second, vitamin D deficiency has become popularly (and
ariably) defined by suppression of counter-regulatory hormone
evels or by risk of chronic disease, resulting in remarkably high
roportions or even majorities of healthy populations being defined
s deficient (2,3). Even if vitamin D is convincingly determined to
revent cardiovascular disease or cancer, as may be quite plausible,
he departure of such metrics from more typical definitions of
eficiency (4) based on prevention of overt deficiency symptoms or
omparable biologic indicators must be explicitly recognized. Such
ovel definitions of deficiency could be arguably justified to reduce
isk of chronic disease in the population because policy makers,
ealth providers, and the public each seem to respond much more
rgently to concerns over individuals having deficient versus
uboptimal exposures. Based on this same logic, however, the
trength, consistency, and breadth of scientific evidence would
rgue for highlighting more strongly the current worldwide pan-
emics of omega-3 deficiency, whole-grain deficiency, vegetable
eficiency, and physical activity deficiency, among others. For
xample, long-chain omega-3 fatty acids have robust associations
ith lower risk of coronary heart disease death in numerous
ell-performed observational studies, including 16 prospective
ohort studies of 326,572 generally healthy individuals from the
.S., Europe, and Asia; significant cardiovascular benefits in 4 of
large randomized controlled trials of dietary or supplement
mega-3s in 36,431 patients with and without established heart
isease; and 10-fold differences in risk of sudden cardiac death
ith modest differences in circulating blood levels (5). At a time
hen the Institute of Medicine is being urged to revise dietary
equirements for vitamin D based on novel definitions of defi-
iency, these considerations and comparisons cannot be over-
ooked.
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We agree with Dr. Mozafarrian that many of the prevalent
ealth problems afflicting modernized societies result from dietary
nd lifestyle factors that are at odds with the evolutionary milieu
or which we remain genetically adapted. Mounting worldwide
eficiencies of fresh vegetables and fruits, outdoor exercise,
mega-3 fatty acids, and vitamin D are all rooted in this funda-
ental displacement from our natural outdoor environment to an
ndoor sedentary lifestyle with a synthetic, highly processed,
alorie-dense, nutritionally barren diet (2). The intuitive solution is
o simulate that natural human diet and lifestyle to the extent that
his is possible and practically achievable (3). Notwithstanding,
any individuals may need daily supplements of vitamin D andmega-3 fats.Dr. Mozafarrian questions whether the apparent cardiovascular
CV) benefits associated with higher vitamin D levels might be
onfounded by outdoor physical and social activities that will
oncomitantly increase vitamin D levels and reduce CV risk. To be
ure, exercise confers powerful CV protection, and some evidence
uggests that physical activity performed outside may be more
eneficial than indoor exercise (4). Indeed, vitamin D produced in
esponse to sun exposure maintains serum 25-hydroxyvitamin D
25(OH)D] levels longer than orally ingested vitamin D (5). Yet
tudies indicate that vitamin D synthesis in response to sunlight is
ighly variable depending on geographic location and season and
n skin pigmentation. Even in locales with abundant sun exposure,
uch as Hawaii and southern Arizona, over 50% of inhabitants
ave been documented to be vitamin-D deficient (6,7). Moreover,
xcessive sunlight exposure in the times and locales characterized
y intense ultraviolet radiation can predispose to skin cancers and
remature skin aging, especially for individuals not genetically
dapted (darker skin pigmentation) for equatorial climates. Thus,
ogical and effective strategies for maintaining normal vitamin D
evels include safe sun exposure (15 to 20 min of daily unprotected
unlight exposure of arms and legs 3 times per week in the spring,
ummer, and fall), and oral vitamin D supplementation. The
efinitions of deficient, normal, and ideal vitamin D levels remain
ontroversial. A target level for 25(OH)D of 30 to 60 ng/ml is safe
nd reasonable based on current data. Most studies indicate that
pward of 50% of Americans have vitamin D 25(OH)D levels
elow 30 ng/ml, which can predispose to many CV problems,
ncluding statin-related myalgias (8).
The safety and efficacy of vitamin D supplementation for
mproving CV health will need to be established with large
andomized controlled clinical trials. Generally, nutritional sup-
lements, when tested in large randomized controlled trials, have
ot improved clinical outcomes. However, 2 notable exceptions
xist: omega-3 and vitamin D. It is likely not coincidental that
hese same 2 essential nutrients are the ones most likely to be
eficient among the American population (3,9). The quantity and
uality of supportive randomized trial data for omega-3 exceeds
hat for vitamin D. Even so, the randomized controlled vitamin D
rials performed to date have shown reductions in total mortality
10), fractures (11), and falls (12) when daily doses of 800 IU
itamin D were used.
Drs. Pilz and Tomaschitz highlight the growing body of
vidence indicating that vitamin D deficiency adversely affects
yocardial function and structure. This almost certainly contrib-
tes to the apparent CV toxicity of vitamin D deficiency.
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